Hong Liu

Array ( [id] => 1149921 [patent_doc_number] => 06770596 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Fused tricyclic compounds, process for their preparation, and herbicidal compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/980398 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12447 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770596.pdf [firstpage_image] =>[orig_patent_app_number] => 09980398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1130993 [patent_doc_number] => 06787541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-07 [patent_title] => 'Thieno-and furopyrimidine derivatives as A2A-receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/958948 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32233 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 356 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787541.pdf [firstpage_image] =>[orig_patent_app_number] => 09958948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240059 [patent_doc_number] => 06686351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Compounds and methods for modulation of estrogen receptors' [patent_app_type] => B2 [patent_app_number] => 10/085999 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 32215 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 834 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686351.pdf [firstpage_image] =>[orig_patent_app_number] => 10085999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127009 [patent_doc_number] => 06790858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-14 [patent_title] => 'Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone' [patent_app_type] => B2 [patent_app_number] => 10/078530 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7533 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 651 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790858.pdf [firstpage_image] =>[orig_patent_app_number] => 10078530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148289 [patent_doc_number] => 06774235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'Trisubstituted 1,3,5-triazine derivatives' [patent_app_type] => B2 [patent_app_number] => 10/067383 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13107 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774235.pdf [firstpage_image] =>[orig_patent_app_number] => 10067383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1105293 [patent_doc_number] => 06812229 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'Carbamate derivative and agricultural/horticultural fungicide' [patent_app_type] => B1 [patent_app_number] => 10/048925 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22726 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1599 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812229.pdf [firstpage_image] =>[orig_patent_app_number] => 10048925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134883 [patent_doc_number] => 06784182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/030186 [patent_app_country] => US [patent_app_date] => 2002-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24863 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784182.pdf [firstpage_image] =>[orig_patent_app_number] => 10030186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342715 [patent_doc_number] => 06586423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/061817 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32667 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586423.pdf [firstpage_image] =>[orig_patent_app_number] => 10061817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342750 [patent_doc_number] => 06586424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/062351 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32804 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586424.pdf [firstpage_image] =>[orig_patent_app_number] => 10062351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016997 [patent_doc_number] => 20020103191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Antitumor dibenzofluorene derivatives' [patent_app_type] => new [patent_app_number] => 10/047301 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5019 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103191.pdf [firstpage_image] =>[orig_patent_app_number] => 10047301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6553672 [patent_doc_number] => 20020111369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Aryl sulfonic acids and derivatives as FSH antagonists' [patent_app_type] => new [patent_app_number] => 10/043442 [patent_app_country] => US [patent_app_date] => 2002-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31969 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111369.pdf [firstpage_image] =>[orig_patent_app_number] => 10043442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517558 [patent_doc_number] => 06500819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Bicyclolactam compounds, use thereof and intermediates for preparing thereof' [patent_app_type] => B2 [patent_app_number] => 10/041555 [patent_app_country] => US [patent_app_date] => 2002-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22650 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500819.pdf [firstpage_image] =>[orig_patent_app_number] => 10041555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093219 [patent_doc_number] => 06825215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => '1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-' [patent_app_type] => B2 [patent_app_number] => 10/043627 [patent_app_country] => US [patent_app_date] => 2002-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29510 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1880 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825215.pdf [firstpage_image] =>[orig_patent_app_number] => 10043627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278679 [patent_doc_number] => 20020107240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'N-substituted glycine derivatives' [patent_app_type] => new [patent_app_number] => 10/039896 [patent_app_country] => US [patent_app_date] => 2002-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6254 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107240.pdf [firstpage_image] =>[orig_patent_app_number] => 10039896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307984 [patent_doc_number] => 20020094980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Certain benzothiazine dioxide endothelin antagonists and processes for their preparation' [patent_app_type] => new [patent_app_number] => 10/006589 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20061 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094980.pdf [firstpage_image] =>[orig_patent_app_number] => 10006589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131483 [patent_doc_number] => 20020077326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => '(S)-hydroxynefazodone antipsychotic therapy' [patent_app_type] => new [patent_app_number] => 09/993130 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6496 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077326.pdf [firstpage_image] =>[orig_patent_app_number] => 09993130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669484 [patent_doc_number] => 20030114468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders' [patent_app_type] => new [patent_app_number] => 10/053475 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129687 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114468.pdf [firstpage_image] =>[orig_patent_app_number] => 10053475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6553212 [patent_doc_number] => 20020111348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Substituted oximes and hydrazones as neurokinin antagonists' [patent_app_type] => new [patent_app_number] => 10/047836 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14319 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111348.pdf [firstpage_image] =>[orig_patent_app_number] => 10047836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415756 [patent_doc_number] => 06521592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity' [patent_app_type] => B2 [patent_app_number] => 10/007172 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69119 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521592.pdf [firstpage_image] =>[orig_patent_app_number] => 10007172 [rel_patent_id] =>[rel_patent_doc_number] =>)